Dat Anthony D, Poon Flora, Pham Kim B T, Doust Jenny
Faculty of Health Sciences and Medicine, Bond University, Gold Coast, Australia.
Cochrane Database Syst Rev. 2012 Feb 15;2012(2):CD008762. doi: 10.1002/14651858.CD008762.pub2.
Aloe vera is a cactus-like perennial succulent belonging to the Liliaceae Family that is commonly grown in tropical climates. Animal studies have suggested that Aloe vera may help accelerate the wound healing process.
To determine the effects of Aloe vera-derived products (for example dressings and topical gels) on the healing of acute wounds (for example lacerations, surgical incisions and burns) and chronic wounds (for example infected wounds, arterial and venous ulcers).
We searched the Cochrane Wounds Group Specialised Register (9 September 2011), the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2011, Issue 3), Ovid MEDLINE (2005 to August Week 5 2011), Ovid MEDLINE (In-Process & Other Non-Indexed Citations 8 September 2011), Ovid EMBASE (2007 to 2010 Week 35), Ovid AMED (1985 to September 2011) and EBSCO CINAHL (1982 to 9 September 2011). We did not apply date or language restrictions.
We included all randomised controlled trials that evaluated the effectiveness of Aloe vera, aloe-derived products and a combination of Aloe vera and other dressings as a treatment for acute or chronic wounds. There was no restriction in terms of source, date of publication or language. An objective measure of wound healing (either proportion of completely healed wounds or time to complete healing) was the primary endpoint.
Two review authors independently carried out trial selection, data extraction and risk of bias assessment, checked by a third review author.
Seven trials were eligible for inclusion, comprising a total of 347 participants. Five trials in people with acute wounds evaluated the effects of Aloe vera on burns, haemorrhoidectomy patients and skin biopsies. Aloe vera mucilage did not increase burn healing compared with silver sulfadiazine (risk ratio (RR) 1.41, 95% confidence interval (CI) 0.70 to 2.85). A reduction in healing time with Aloe vera was noted after haemorrhoidectomy (RR 16.33 days, 95% CI 3.46 to 77.15) and there was no difference in the proportion of patients completely healed at follow up after skin biopsies. In people with chronic wounds, one trial found no statistically significant difference in pressure ulcer healing with Aloe vera (RR 0.10, 95% CI -1.59 to 1.79) and in a trial of surgical wounds healing by secondary intention Aloe vera significantly delayed healing (mean difference 30 days, 95% CI 7.59 to 52.41). Clinical heterogeneity precluded meta-analysis. The poor quality of the included trials indicates that the trial results must be viewed with extreme caution as they have a high risk of bias.
AUTHORS' CONCLUSIONS: There is currently an absence of high quality clinical trial evidence to support the use of Aloe vera topical agents or Aloe vera dressings as treatments for acute and chronic wounds.
芦荟是一种仙人掌类多年生肉质植物,属于百合科,通常生长在热带气候地区。动物研究表明,芦荟可能有助于加速伤口愈合过程。
确定芦荟衍生产品(如敷料和外用凝胶)对急性伤口(如撕裂伤、手术切口和烧伤)和慢性伤口(如感染伤口、动脉和静脉溃疡)愈合的影响。
我们检索了Cochrane伤口小组专业注册库(2011年9月9日)、Cochrane对照试验中央注册库(CENTRAL)(《Cochrane图书馆》2011年第3期)、Ovid MEDLINE(2005年至2011年8月第5周)、Ovid MEDLINE(在研及其他非索引引文,2011年9月8日)、Ovid EMBASE(2007年至2010年第35周)、Ovid AMED(1985年至2011年9月)和EBSCO CINAHL(1982年至2011年9月9日)。我们未施加日期或语言限制。
我们纳入了所有评估芦荟、芦荟衍生产品以及芦荟与其他敷料组合作为急性或慢性伤口治疗方法有效性的随机对照试验。在来源、出版日期或语言方面没有限制。伤口愈合的客观测量指标(完全愈合伤口的比例或完全愈合的时间)是主要终点。
两位综述作者独立进行试验选择、数据提取和偏倚风险评估,由第三位综述作者进行检查。
七项试验符合纳入标准,共包括347名参与者。五项针对急性伤口患者的试验评估了芦荟对烧伤患者、痔切除术后患者和皮肤活检患者的影响。与磺胺嘧啶银相比,芦荟黏液并未增加烧伤愈合(风险比(RR)1.41,95%置信区间(CI)0.70至2.85)。痔切除术后使用芦荟可缩短愈合时间(RR 16.33天,95% CI 3.46至77.15),皮肤活检后随访时完全愈合患者的比例无差异。在慢性伤口患者中,一项试验发现芦荟治疗压疮愈合方面无统计学显著差异(RR 0.10,95% CI -1.59至1.79),在一项二期愈合手术伤口的试验中,芦荟显著延迟了愈合(平均差异30天,95% CI 7.59至52.41)。临床异质性妨碍了荟萃分析。纳入试验的质量较差表明,试验结果必须极其谨慎地看待,因为它们存在较高的偏倚风险。
目前缺乏高质量的临床试验证据支持使用芦荟外用制剂或芦荟敷料治疗急性和慢性伤口。